Table 2 Risk factor analysis for epilepsy.
Risk factors | Seizures (n/all, %) | No seizures (n/all, %) | OR | OR 95%CI | χ2 | P Value |
---|---|---|---|---|---|---|
Male | 26/36 72.2 | 102/178 57.3 | 0.516 | 0.235–1.135 | 2.709 | 0.100 |
Age ≥ 60 | 13/36 36.1 | 109/178 61.2 | 0.358 | 0.170–0.753 | 7.332 | 0.007 |
EEG abnormal | 21/25 84.0 | 46/67 68.7 | 2.397 | 0.731–7.857 | 2.082 | 0.149 |
Edema zone(≥ 1 cm) | 25/33 75.6 | 88/172 51.2 | 2.983 | 1.274–2.982 | 6.344 | 0.012 |
Location of lesion | ||||||
Cortical involvement | 26/34 76.5 | 39/169 23.1 | 10.833 | 4.541–25.846 | 28.847 | 0.000 |
Bilateral frontal lobes involvement | 7/33 21.2 | 10/141 7.1 | 3.527 | 1.230–10.115 | 5.498 | 0.019 |
Brainstem involvement | 8/33 24.2 | 16/141 11.3 | 2.500 | 0.966–6.427 | 3.565 | 0.059 |
PIM1 mutation | 1/10 10.0 | 14/23 60.87 | 0.071 | 0.008–0.664 | 5.384 | 0.020 |
AEDs | 9/16 56.2 | 102/178 57.3 | 0.980 | 0.349–2.749 | 0.007 | 0.970 |
Response to MTX (CR/PR) | 6/15 40.0 | 95/170 55.9 | 0.526 | 0.179–1.544 | 1.366 | 0.243 |